Skip to main content
Erschienen in: Osteoporosis International 1/2013

01.01.2013 | Original Article

QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis

Erschienen in: Osteoporosis International | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Summary

Bone mineral density (BMD) declined in more than half (53.7%) of post-total knee arthroplasty (TKA) patients (44 of the 82) after 1 year of oral bisphosphonate treatment, and that this decline was significant in bilateral TKA patients.

Introduction

TKA has proven to be an extremely successful procedure in terms of improving ambulatory function. However, the effects of such improvements in ambulatory function and of bisphosphonate on axial BMD have not been established. The purpose of this study was to determine the effect of 1 year of oral bisphosphonate in postmenopausal patients that have undergone TKA and to identify factors related to BMD changes using lumbar spine quantitative computed tomography (QCT).

Methods

Eighty-two postmenopausal women that underwent primary TKA for knee osteoarthritis and who received once-weekly oral alendronate 70 mg for 12 months after TKA were enrolled. The effect of 1 year of oral bisphosphonate treatment post-TKA and the factors related to general lumbar spine BMD changes by using QCT were determined.

Results

Some 53.7% of patients (44 of the 82) experienced an average lumbar spine QCT BMD decline of −6 mg/ml (range −15 to −0.5 mg/ml) after 1 year of oral bisphosphonate treatment, whereas the remaining 38 patients (46.3%) experienced an average increase of 6.8 mg/ml (range 0.6 to 15.7 mg/ml). Logistic and linear regression analysis showed that bilateral TKA was significantly related to a BMD decline (p < 0.05). Other factors, such as, age, body mass index, number of comorbidities, and Knee Society scores were not found to be significantly related to BMD response.

Conclusions

BMD declined in more than half (53.7%) of the patients after bisphosphonate treatment, and that this decline was significant in bilateral TKA patients. We believe that reduced mobility during rehabilitation was probably responsible for these BMD reductions.
Literatur
1.
Zurück zum Zitat Nevitt MC, Lane NE, Scott JC, Hochberg MC, Pressman AR, Genant HK, Cummings SR (1995) Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum 38:907–916PubMedCrossRef Nevitt MC, Lane NE, Scott JC, Hochberg MC, Pressman AR, Genant HK, Cummings SR (1995) Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum 38:907–916PubMedCrossRef
2.
Zurück zum Zitat Hannan MT, Anderson JJ, Zhang Y, Levy D, Felson DT (1993) Bone mineral density and knee osteoarthritis in elderly men and women. Arthritis Rheum 36:1671–1680PubMedCrossRef Hannan MT, Anderson JJ, Zhang Y, Levy D, Felson DT (1993) Bone mineral density and knee osteoarthritis in elderly men and women. Arthritis Rheum 36:1671–1680PubMedCrossRef
3.
Zurück zum Zitat Arden NK, Crozier S, Smith H, Anderson F, Edwards C, Raphael H, Cooper C (2006) Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum 55:610–615PubMedCrossRef Arden NK, Crozier S, Smith H, Anderson F, Edwards C, Raphael H, Cooper C (2006) Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum 55:610–615PubMedCrossRef
4.
Zurück zum Zitat Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Kiran A, Cooper C, Arden NK (2011) Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis. Osteoporos Int 22:1555–1571PubMedCrossRef Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Kiran A, Cooper C, Arden NK (2011) Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis. Osteoporos Int 22:1555–1571PubMedCrossRef
5.
Zurück zum Zitat Minoda Y, Ikebuchi M, Kobayashi H, Iwaki H, Inori F, Nakamura H (2010) A cemented mobile-bearing total knee replacement prevents periprosthetic loss of bone mineral density around the femoral component: a matched cohort study. J Bone Joint Surg Br 92-B(6):794–798CrossRef Minoda Y, Ikebuchi M, Kobayashi H, Iwaki H, Inori F, Nakamura H (2010) A cemented mobile-bearing total knee replacement prevents periprosthetic loss of bone mineral density around the femoral component: a matched cohort study. J Bone Joint Surg Br 92-B(6):794–798CrossRef
6.
Zurück zum Zitat van Loon CJ, Oyen WJ, de Waal Malefijt MC, Verdonschot N (2001) Distal femoral bone mineral density after total knee arthroplasty: a comparison with general bone mineral density. Arch Orthop Trauma Surg 121:282–285PubMedCrossRef van Loon CJ, Oyen WJ, de Waal Malefijt MC, Verdonschot N (2001) Distal femoral bone mineral density after total knee arthroplasty: a comparison with general bone mineral density. Arch Orthop Trauma Surg 121:282–285PubMedCrossRef
7.
Zurück zum Zitat Abu-Rajab RB, Watson WS, Walker B, Roberts J, Gallacher SJ, Meek RM (2006) Peri-prosthetic bone mineral density after total knee arthroplasty: cemented versus cementless fixation. J Bone Joint Surg Br 88-B:606–613CrossRef Abu-Rajab RB, Watson WS, Walker B, Roberts J, Gallacher SJ, Meek RM (2006) Peri-prosthetic bone mineral density after total knee arthroplasty: cemented versus cementless fixation. J Bone Joint Surg Br 88-B:606–613CrossRef
8.
Zurück zum Zitat Soininvaara TA, Jurvelin JS, Miettinen HJA, Suomalainen OT, Alhava EM, Kroger PJ (2002) Effect of alendronate on periprosthetic bone loss after total knee Arthroplasty: a one-year, randomized, controlled trial of 19 patient. Calcif Tissue Int 71:472–477PubMedCrossRef Soininvaara TA, Jurvelin JS, Miettinen HJA, Suomalainen OT, Alhava EM, Kroger PJ (2002) Effect of alendronate on periprosthetic bone loss after total knee Arthroplasty: a one-year, randomized, controlled trial of 19 patient. Calcif Tissue Int 71:472–477PubMedCrossRef
9.
Zurück zum Zitat Lewiecki EM, Keaveny TM, Kopperdahl DL, Genant HK, Engelke K, Fuerst T, Kivitz A, Davies RY, Fitzpatrick LA (2009) Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 94:171–180PubMedCrossRef Lewiecki EM, Keaveny TM, Kopperdahl DL, Genant HK, Engelke K, Fuerst T, Kivitz A, Davies RY, Fitzpatrick LA (2009) Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 94:171–180PubMedCrossRef
10.
Zurück zum Zitat Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D (1999) Large increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Arthritis Rheum 42:1246–1254PubMedCrossRef Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D (1999) Large increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Arthritis Rheum 42:1246–1254PubMedCrossRef
11.
Zurück zum Zitat Powell RS, Pulido P, Tuason MS, Colwell CW Jr, Ezzet KA (2006) Bilateral vs unilateral total knee arthroplasty: a patient-based comparison of pain levels and recovery of ambulatory skills. J Arthroplasty 21:642–649PubMedCrossRef Powell RS, Pulido P, Tuason MS, Colwell CW Jr, Ezzet KA (2006) Bilateral vs unilateral total knee arthroplasty: a patient-based comparison of pain levels and recovery of ambulatory skills. J Arthroplasty 21:642–649PubMedCrossRef
12.
Zurück zum Zitat Sebba AI (2008) Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment. Clin Ther 30:443–452PubMedCrossRef Sebba AI (2008) Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment. Clin Ther 30:443–452PubMedCrossRef
13.
Zurück zum Zitat Recker RR, Gallagher R, Maccosbe PE (2005) Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80:856–861PubMedCrossRef Recker RR, Gallagher R, Maccosbe PE (2005) Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80:856–861PubMedCrossRef
14.
Zurück zum Zitat Francis RM (2004) Non-response to osteoporosis treatment. J Br Menopause Soc 10:76–80PubMed Francis RM (2004) Non-response to osteoporosis treatment. J Br Menopause Soc 10:76–80PubMed
15.
Zurück zum Zitat Bonnick SL, Johnston CC Jr, Kleerekoper M, Lindsay R, Miller P, Sherwood L, Siris E (2001) Importance of precision in bone density measurements. J Clin Densitom 4:105–111PubMedCrossRef Bonnick SL, Johnston CC Jr, Kleerekoper M, Lindsay R, Miller P, Sherwood L, Siris E (2001) Importance of precision in bone density measurements. J Clin Densitom 4:105–111PubMedCrossRef
16.
Zurück zum Zitat Oppenheimer L, Kher U (1999) The impact of measurement error on the comparison of two treatments using a responder analysis. Stat Med 18:2177–2188PubMedCrossRef Oppenheimer L, Kher U (1999) The impact of measurement error on the comparison of two treatments using a responder analysis. Stat Med 18:2177–2188PubMedCrossRef
17.
Zurück zum Zitat Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 11:75–91PubMedCrossRef Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 11:75–91PubMedCrossRef
18.
Zurück zum Zitat Carey JJ (2005) What is a ‘failure’ of bisphosphonate therapy for osteoporosis? Cleve Clin J Med 72:1033–1039PubMedCrossRef Carey JJ (2005) What is a ‘failure’ of bisphosphonate therapy for osteoporosis? Cleve Clin J Med 72:1033–1039PubMedCrossRef
19.
Zurück zum Zitat Kilgus DJ, Shimaoka EE, Tipton JS, Eberle RW (1993) Dual-energy X-ray absorptiometry measurement of bone mineral density around porous-coated cementless femoral implants. Methods and preliminary results. J Bone Joint Surg Br 75-B:279–287 Kilgus DJ, Shimaoka EE, Tipton JS, Eberle RW (1993) Dual-energy X-ray absorptiometry measurement of bone mineral density around porous-coated cementless femoral implants. Methods and preliminary results. J Bone Joint Surg Br 75-B:279–287
20.
Zurück zum Zitat Delmas PD, Seeman E (2004) Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 34:599–604PubMedCrossRef Delmas PD, Seeman E (2004) Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 34:599–604PubMedCrossRef
21.
Zurück zum Zitat Engelke K, Adams JE, Armbrecht G, Augat P, Bogado CE, Bouxsein ML, Felsenberg D, Ito M, Prevrhal S, Hans DB, Lewiecki EM (2008) Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults. J Clin Densitom 11:123–162PubMedCrossRef Engelke K, Adams JE, Armbrecht G, Augat P, Bogado CE, Bouxsein ML, Felsenberg D, Ito M, Prevrhal S, Hans DB, Lewiecki EM (2008) Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults. J Clin Densitom 11:123–162PubMedCrossRef
22.
Zurück zum Zitat Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Judge A, Nevitt M, Cooper C, Arden NK (2010) Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis 70:134–138PubMedCrossRef Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Judge A, Nevitt M, Cooper C, Arden NK (2010) Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis 70:134–138PubMedCrossRef
23.
Zurück zum Zitat Birdsall PD, Hayes JH, Cleary R, Pinder IM, Moran CG, Sher JL (1999) Health outcome after total knee replacement in the very elderly. J Bone Joint Surg Br 81-B:660–662CrossRef Birdsall PD, Hayes JH, Cleary R, Pinder IM, Moran CG, Sher JL (1999) Health outcome after total knee replacement in the very elderly. J Bone Joint Surg Br 81-B:660–662CrossRef
24.
Zurück zum Zitat Lalmohamed A, Opdam F, Arden NK, Prieto-Alhambra D, van Staa T, Leufkens HG, de Vries F (2012) Knee arthroplasty and risk of hip fracture: a population-based, case–control study. Calcif Tissue Int 90(2):144–150PubMedCrossRef Lalmohamed A, Opdam F, Arden NK, Prieto-Alhambra D, van Staa T, Leufkens HG, de Vries F (2012) Knee arthroplasty and risk of hip fracture: a population-based, case–control study. Calcif Tissue Int 90(2):144–150PubMedCrossRef
25.
Zurück zum Zitat Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Kiran A, de Vries F, Cooper C, Arden NK (2011) Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum 63:992–1001PubMedCrossRef Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Kiran A, de Vries F, Cooper C, Arden NK (2011) Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum 63:992–1001PubMedCrossRef
Metadaten
Titel
QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis
Publikationsdatum
01.01.2013
Erschienen in
Osteoporosis International / Ausgabe 1/2013
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-012-1925-x

Weitere Artikel der Ausgabe 1/2013

Osteoporosis International 1/2013 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.